• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Calendar eNews, DF/HCC's online quarterly newsletter, highlights the groundbreaking research, news, and events taking place within DF/HCC, and showcases the services and tools DF/HCC offers to facilitate collaboration and discovery in the Harvard community.

Welcome to Dana-Farber/Harvard Cancer Center

Dana-Farber/Harvard Cancer Center (DF/HCC) is the largest comprehensive cancer center in the world, bringing together the cancer research efforts of our seven member institutions: Beth Israel Deaconess Medical Center, Brigham and Women’s Hospital, Children’s Hospital Boston, Dana-Farber Cancer Institute, Harvard Medical School, Harvard School of Public Health, and Massachusetts General Hospital.

Funded by a grant from the National Cancer Institute, we have joined these seven renowned Harvard-affiliated medical centers into one collective force dedicated to the fight against cancer. Based in Boston, DF/HCC consists of more than 1,000 researchers with a singular goal — to find new and innovative ways to combat cancer.


Latest Cancer News

    Thinking therapeutically: Scientists in search of smarter tests and treatments for prostate cancer

    Even though prostate cancer is the second leading cause of cancer death in men in the United States, some patients may wonder whether treatment is worse than the disease. The... | [more]

    Beyond survival: Bettering men’s quality of life following prostate cancer treatment

    Few clinicians understand the consequences of prostate cancer treatment better than urological surgeon-scientist Martin Sanda, MD, director of the multidisciplinary prostate... | [more]

    Unique randomized trial tests VEGF inhibitor in patients with recurrent glioblastoma

    Glioblastoma, the most common and lethal type of malignant brain tumor, has a poor prognosis and very few chemotherapeutic options. Despite surgery, radiotherapy, and... | [more]

    Health Communication Core

    The Health Communication Core provides communication support in areas such as cancer prevention education and communication, recruitment to clinical research studies,... | [more]